EcoDrugPlus

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSDCDG00000003646
Gene Symbol: SYK
3 Cross references
203 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase

Ensembl ID : ENSDCDG00000004968
Gene Symbol: LOC114795163
3 Cross references
211 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSDCDG00000021383
Gene Symbol: SRD5A2
3 Cross references
208 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSDCDG00000028005
Gene Symbol: SOAT1
3 Cross references
211 Possible Orthologues:

Substance-P Receptor-Like

Ensembl ID : ENSDCDG00000025787
Gene Symbol: LOC114786548
3 Cross references
194 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSDCDG00000018159
Gene Symbol: TACR1
3 Cross references
215 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSDCDG00000030348
Gene Symbol: TACR2
3 Cross references
200 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSDCDG00000034688
Gene Symbol: TACR3
3 Cross references
141 Possible Orthologues:

Target Of Rapamycin Complex Subunit Lst8

Ensembl ID : ENSDCDG00000028275
Gene Symbol: LOC114772605
3 Cross references
194 Possible Orthologues:

Target Of Rapamycin Complex Subunit Lst8

Ensembl ID : ENSDCDG00000029298
Gene Symbol: LOC114795794
3 Cross references
194 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSDCDG00000027427
Gene Symbol: TERT
3 Cross references
188 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSDCDG00000007194
Gene Symbol: TBXAS1
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).